Sure-Tech: How Much of GeoX's Value Really Depends on a Major Client and a Legal Reset
After the write-down, GeoX still sits in Sure-Tech's books at NIS 7.2 million, but that mark rests on a much narrower path than a quick read of the annual disclosure suggests. On one side there is more than 18 months of funding runway and no single-customer dependence, and on the other the valuation explicitly says the fair value can approach zero without a very material customer and without a legal reset.
The main article argued that Sure-Tech's discount is first and foremost a question of access to value. This follow-up isolates GeoX because even after the 2025 write-down it is still carried at NIS 7.20 million, roughly 22.5% of Sure-Tech's investment portfolio. So the question is no longer whether damage was done. That is already clear. The question is what exactly still supports the value that remains.
A quick read of the GeoX disclosure can look almost reassuring. There are two named material customers, Geoscape Australia and MS&AD, there are projects and implementation tests with insurers and aerial-imagery companies, there is no dependence on any single customer, and according to GeoX the company's financial resources should be sufficient for more than 18 months. But that is only the survivability layer. The attached valuation opens a very different layer: the value is built on an optimistic case in which a very material customer is signed in the near term, and if that does not happen and the legal process continues, fair value becomes negligible and approaches zero.
That is the core point. This is not a simple accounting contradiction. It is two different levels of truth. The current disclosure says GeoX still has oxygen. The valuation says that for Sure-Tech's remaining NIS 7.2 million mark to hold, that oxygen has to turn fairly quickly into a commercial and legal reset.
Where The Gap Really Sits
There is another subtle point that is easy to miss: even the comforting layer is not hard audited comfort. GeoX itself said that 2025 revenue fell materially versus 2024, but it also made clear that its 2025 financial statements were not yet complete, that the information was based on ongoing budget monitoring, and that the data was not prepared under accepted accounting rules and was not audited or reviewed. The more-than-18-month funding-runway statement comes from that same layer. In other words, readers are not looking at a fully audited operating picture on one side and an aggressive valuation on the other. They are looking at two management-driven layers that answer different questions.
| Layer | What it says | What it means for Sure-Tech holders |
|---|---|---|
| Current commercial base | Geoscape Australia and MS&AD are presented as material customers, with additional projects and partnerships across insurers, aerial imagery, and mapping services | There is real activity and there are real customers, but that does not answer what supports the remaining valuation |
| Customer concentration | GeoX says it has no dependence on any single customer as of the report date | That describes the current revenue mix, not the future value driver |
| Liquidity | GeoX says its financial resources should be sufficient for more than 18 months | The company has time to attempt a reset, but that is not a valuation floor |
| Upside engine in the valuation | Major client A is in final contract stages with expected revenue of about $11 million over 3 years, and major client B has a 4 year agreement worth AUD 21 million | Future value rests on a small number of heavy commercial events, not on broad diversification |
| Legal layer | The dispute with round investors stopped the second closing, and one investor filed suit. The valuation says that if the legal process continues and the major client is not signed, fair value approaches zero | The legal process is not side noise. It is part of the valuation core |
That is why the sentence "no dependence on a single customer" does not really contradict the sentence "the value depends on a very material customer." The first describes current revenue concentration. The second describes what has to happen for the remaining upside to be justified. For Sure-Tech holders, the second sentence matters more because it is the one carrying the NIS 7.2 million mark.
The key point in this chart is not only the size of the write-down. It is the fact that even after a NIS 19.74 million hit, GeoX is still a material asset in the portfolio. This is not a historical issue. It still shapes how Sure-Tech's reported value should be read today.
What The Valuation Model Is Actually Assuming
To understand how narrow the remaining value is, the valuation needs to be read as a business thesis rather than as a spreadsheet exercise. According to the valuation, 2025 was a difficult year because of significant internal issues, not because of a market or technology problem. Management redefined the company's core around The US Database, and distribution is now centered on two channels: an API for fast access and a platform meant to create more stickiness with the customer.
But the same document ties the legal crisis directly to operations. It says one investor from the round filed a claim against the company and its senior officers, and that the process led to the loss of critical personnel, including the VP of R&D and sales engineers, and to a retreat from the Japanese market. On top of that, 2025 is framed as a restructuring year: the company grew to a peak of 44 employees, was cut back to 26 in the third quarter, and in 2026 plans another three cuts alongside six strategic hires, including an EVP Sales and two SDR roles.
This is not the picture of a business simply continuing on its path. It is the picture of a company trying to rebuild its revenue path after a trust break and an organizational shock. The numbers in the valuation reflect that. Operating profit is expected to rise from $1.663 million in 2026 to $6.374 million by 2030, and forecast cash flow is expected to move from $414 thousand to $4.818 million across those years.
Methodology was not especially forgiving either. The weighted average cost of capital was set at 22%, long-term growth at 3%, the small-company risk premium at 10.4%, and an additional 2% company-specific premium was added on top. In other words, the real debate here is not whether the model used an easy discount rate. The real debate is whether the commercial and legal path sitting underneath that relatively harsh discount rate will actually materialize.
It is also important to understand where the real model risk sits. In Sure-Tech's note, GeoX's valuation is described as a DCF topped with an OPM layer to allocate value to Sure-Tech's preferred shares, with 36% volatility and about a 4 year liquidity horizon. That layer matters for splitting value across share classes, but it is not the engine. The engine is the DCF. If the major client does not land and the legal process does not calm down, the OPM layer will not save the mark.
Why The Real Risk Sits Outside The Sensitivity Grid
The standard sensitivity table can be misleading because it looks fairly orderly. With long-term growth kept at 3%, value ranges from $27.155 million at a 20% discount rate to $22.243 million at a 24% discount rate. That is a meaningful spread, but it still leaves the mark in the same broad neighborhood. That is normal parameter sensitivity.
But the valuation itself says explicitly that the downside case is not just another 100 basis points of discount rate or another point of terminal growth. The downside case is one in which the company does not sign that very material customer and the legal process continues. In that case, it says, the company will not be able to raise capital and its fair value becomes negligible and approaches zero. That is no longer parameter tweaking. That is thesis breakage.
This is where the fault line runs inside Sure-Tech's GeoX mark. Most of the risk does not sit in the cell for 22% versus 23% WACC or 3% versus 2% long-term growth. It sits in whether there is a real commercial reset that turns pipeline into a signed contract, and a real legal reset that restores capital access without a major cloud over the last funding round.
The more-than-18-month funding statement has to be read the same way. According to the valuation balance-sheet summary, GeoX ended 2025 with $3.051 million of cash and cash equivalents and $3.251 million of equity. That gives the company oxygen. Oxygen is not a valuation floor. It only means there is time to try to prove the model again, sign the major customer, and get through the legal overhang without an immediate emergency raise. Until those three things are resolved, Sure-Tech's GeoX mark remains much closer to a weighted option than to a stabilized asset.
Conclusion
After the 2025 write-down, it is easy to assume GeoX has already been cleaned out of the portfolio and that what remains is a relatively conservative mark. That is not the right read. The remaining NIS 7.2 million in Sure-Tech's books is not a floor supported simply by customers, cash, and time. It is the result of a weighted outcome between a recovery case in which a very material customer is signed and the legal system calms down, and a break case in which those things do not happen and value becomes negligible.
That also explains why the market is still unwilling to give Sure-Tech's NAV full credit. The main article framed the issue as access to value. This continuation shows the problem is even deeper: even after the write-down, one of the portfolio's key assets still depends on a relatively concentrated commercial event and on a legal reset that has not yet been proven. The fact that there is no current single-customer dependence does not change that, because the dependence has shifted from current revenue concentration to future value concentration.
What has to happen in 2026 for this mark to hold? Not another model, but evidence. A material contract that moves from pipeline to revenue, real de-escalation in the dispute with the round investors, and signs that the US Database and the API are moving GeoX back from reset mode to a credible commercialization path. Without that, the NIS 7.2 million will remain much more a model output than a value that has actually stabilized.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.